Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Stem Cell Research
|
December 7, 2010
Sox2 expression effects on direct reprogramming efficiency as determined by alternative somatic cell fate
Shinpei Yamaguchi, Kunio Hirano, Shogo Nagata, et al.
Development (Cambridge, England)
|
December 15, 2015
OCT4 activity during conversion of human intermediately reprogrammed stem cells to iPSCs through mesenchymal-epithelial transition
Rika Teshigawara, Kunio Hirano, Shogo Nagata, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms
|
August 7, 2019
Visualization of sequential conversion of human intermediately reprogrammed stem cells into iPS cells
Rika Teshigawara, Kunio Hirano, Shogo Nagata, et al.
Plos One
|
November 13, 2012
Self-renewal and pluripotency acquired through somatic reprogramming to human cancer stem cells
Shogo Nagata, Kunio Hirano, Michele Kanemori, et al.
Developmental Biology
|
June 15, 2014
Nanog co-regulated by Nodal/Smad2 and Oct4 is required for pluripotency in developing mouse epiblast
Liang Tso Sun, Shinpei Yamaguchi, Kunio Hirano, et al.
Biochemical and Biophysical Research Communications
|
April 17, 2017
Closed-channel culture system for efficient and reproducible differentiation of human pluripotent stem cells into islet cells
Kunio Hirano, Shuhei Konagaya, Alexander Turner, et al.
Plos One
|
February 21, 2012
Cure of ADPKD by selection for spontaneous genetic repair events in Pkd1-mutated iPS cells
Li-Tao Cheng, Shogo Nagata, Kunio Hirano, et al.
Stem Cells and Development
|
September 3, 2011
Human and mouse induced pluripotent stem cells are differentially reprogrammed in response to kinase inhibitors
Kunio Hirano, Shogo Nagata, Shinpei Yamaguchi, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms
|
November 19, 2022
Intranasal Sendai virus-based SARS-CoV-2 vaccine using a mouse model
Satoru Morimoto, Koichi Saeki, Masaru Takeshita, et al.
Annals of Palliative Medicine
|
November 22, 2021
Combination treatment with bevacizumab plus erlotinib for meningeal carcinomatosis of afatinib-resistant EGFR mutated lung cancer without T790M mutation: a case report
Shinji Chiba, Masachika Akiyama, Kazuhiro Yakuwa, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Stem Cell Research
|
December 7, 2010
Sox2 expression effects on direct reprogramming efficiency as determined by alternative somatic cell fate
Shinpei Yamaguchi, Kunio Hirano, Shogo Nagata, et al.
Development (Cambridge, England)
|
December 15, 2015
OCT4 activity during conversion of human intermediately reprogrammed stem cells to iPSCs through mesenchymal-epithelial transition
Rika Teshigawara, Kunio Hirano, Shogo Nagata, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms
|
August 7, 2019
Visualization of sequential conversion of human intermediately reprogrammed stem cells into iPS cells
Rika Teshigawara, Kunio Hirano, Shogo Nagata, et al.
Plos One
|
November 13, 2012
Self-renewal and pluripotency acquired through somatic reprogramming to human cancer stem cells
Shogo Nagata, Kunio Hirano, Michele Kanemori, et al.
Developmental Biology
|
June 15, 2014
Nanog co-regulated by Nodal/Smad2 and Oct4 is required for pluripotency in developing mouse epiblast
Liang Tso Sun, Shinpei Yamaguchi, Kunio Hirano, et al.
Biochemical and Biophysical Research Communications
|
April 17, 2017
Closed-channel culture system for efficient and reproducible differentiation of human pluripotent stem cells into islet cells
Kunio Hirano, Shuhei Konagaya, Alexander Turner, et al.
Plos One
|
February 21, 2012
Cure of ADPKD by selection for spontaneous genetic repair events in Pkd1-mutated iPS cells
Li-Tao Cheng, Shogo Nagata, Kunio Hirano, et al.
Stem Cells and Development
|
September 3, 2011
Human and mouse induced pluripotent stem cells are differentially reprogrammed in response to kinase inhibitors
Kunio Hirano, Shogo Nagata, Shinpei Yamaguchi, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms
|
November 19, 2022
Intranasal Sendai virus-based SARS-CoV-2 vaccine using a mouse model
Satoru Morimoto, Koichi Saeki, Masaru Takeshita, et al.
Annals of Palliative Medicine
|
November 22, 2021
Combination treatment with bevacizumab plus erlotinib for meningeal carcinomatosis of afatinib-resistant EGFR mutated lung cancer without T790M mutation: a case report
Shinji Chiba, Masachika Akiyama, Kazuhiro Yakuwa, et al.
Page
of 2